|
2024 Journal Article Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialChang, Anne B., Yerkovich, Stephanie T., Baines, Katherine J., Burr, Lucy, Champion, Anita, Chatfield, Mark D., Eg, Kah P, Goyal, Vikas, Marsh, Robyn L, McCallum, Gabrielle B, McElrea, Margaret, McPhail, Steven, Morgan, Lucy C, Morris, Peter S, Nathan, Anne M, O’Farrell, Hannah, Sanchez, Marion O, Parsons, Marianne, Schultz, André, Torzillo, Paul J, West, Nicholas P, Versteegh, Lesley, Marchant, Julie M and Grimwood, Keith (2024). Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respiratory Research, 11 (1) e002216, e002216. doi: 10.1136/bmjresp-2023-002216 |
|
2024 Journal Article Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialFeigl, Beatrix, Lewis, Simon J.G., Burr, Lucy D., Schweitzer, Daniel, Gnyawali, Subodh, Vagenas, Dimitrios, Carter, Drew D. and Zele, Andrew J. (2024). Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial. eClinicalMedicine, 69 102474, 102474. doi: 10.1016/j.eclinm.2024.102474 |
|
2024 Conference Publication Evaluating the clinical utility of routine nasal nitric oxideMadden, G., Carballo, A. and Burr, L. (2024). Evaluating the clinical utility of routine nasal nitric oxide. HOBOKEN: WILEY. |
|
2024 Conference Publication Plasma sulphate levels are elevated in bronchiectasisBurr, L., Kelly, S., Anderson, S., McWhinney, A. and Dawson, P. (2024). Plasma sulphate levels are elevated in bronchiectasis. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Gold Coast, QLD, Australia, 22–26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673 |
|
2023 Journal Article The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variantPegg, Cassandra L., Modhiran, Naphak, Parry, Rhys H., Liang, Benjamin, Amarilla, Alberto A., Khromykh, Alexander A., Burr, Lucy, Young, Paul R., Chappell, Keith, Schulz, Benjamin L. and Watterson, Daniel (2023). The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant. Glycobiology, 34 (2) cwad097, 1-13. doi: 10.1093/glycob/cwad097 |
|
2023 Journal Article Elevated BMI reduces the humoral response to SARS‐CoV‐2 infectionTong, Marcus Z. W., Sng, Julian D. J., Carney, Meagan, Cooper, Lucy, Brown, Samuel, Lineburg, Katie E., Chew, Keng Yih, Collins, Neve, Ignacio, Kirsten, Airey, Megan, Burr, Lucy, Joyce, Briony A., Jayasinghe, Dhilshan, McMillan, Christopher L. D., Muller, David A., Adhikari, Anurag, Gallo, Linda A., Dorey, Emily S., Barrett, Helen L., Gras, Stephanie, Smith, Corey, Good‐Jacobson, Kim and Short, Kirsty R. (2023). Elevated BMI reduces the humoral response to SARS‐CoV‐2 infection. Clinical and Translational Immunology, 12 (12) e1476, 1-13. doi: 10.1002/cti2.1476 |
|
2023 Journal Article Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina cladesPham, Amy, Volmer, James G., Chambers, Daniel C., Smith, Daniel J., Reid, David W., Burr, Lucy and Wells, Timothy J. (2023). Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina clades. Frontiers in Microbiology, 14 1274280, 1-14. doi: 10.3389/fmicb.2023.1274280 |
|
2023 Journal Article The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic controlChoo, Jocelyn M., Martin, Alyce M., Taylor, Steven L., Sun, Emily, Mobegi, Fredrick M., Kanno, Tokuwa, Richard, Alyson, Burr, Lucy D., Lingman, Stevie, Martin, Megan, Keating, Damien J., Mason, A. James and Rogers, Geraint B. (2023). The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic control. Microbiology Spectrum, 11 (4). doi: 10.1128/spectrum.00831-23 |
|
2023 Conference Publication Biologic switching in severe asthma: Observations from an Australian patient cohortNewman, B., Burr, L., Bowler, S. and Barnett, A. (2023). Biologic switching in severe asthma: Observations from an Australian patient cohort. HOBOKEN: WILEY. |
|
2023 Journal Article Subjective and objective sleep quality does not predict behavioural episodic foresight in younger or older adultsDemichelis, Olivia P., Grainger, Sarah A., McKay, Kate T., Burr, Lucy, Kim, Joanne and Henry, Julie D. (2023). Subjective and objective sleep quality does not predict behavioural episodic foresight in younger or older adults. Scientific Reports, 13 (1) 1056, 1-10. doi: 10.1038/s41598-023-28183-1 |
|
2023 Journal Article Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsUluer, Ahmet Z, MacGregor, Gordon, Azevedo, Pilar, Indihar, Veronica, Keating, Claire, Mall, Marcus A, McKone, Edward F, Ramsey, Bonnie W, Rowe, Steven M, Rubenstein, Ronald C, Taylor-Cousar, Jennifer L, Tullis, Elizabeth, Yonker, Lael M, Chu, Chenghao, Lam, Anna P, Nair, Nitin, Sosnay, Patrick R, Tian, Simon, Van Goor, Fredrick, Viswanathan, Lakshmi, Waltz, David, Wang, Linda T, Xi, Yingmei, Billings, Joanne, Horsley, Alexander, Nash, Edward F., Bakker, Marleen, van der Meer, Renske, Merkus, Petrus ... Wilson, John (2023). Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6), 550-562. doi: 10.1016/S2213-2600(22)00504-5 |
|
2023 Journal Article ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation settingLee, Annemarie L., Smith, Rebecca, Burr, Lucy, Chang, Anne B., Holmes‐Liew, Chien‐Li, King, Paul, Middleton, Peter, Morgan, Lucy, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and McAleer, Rachael (2023). ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation setting. The Clinical Respiratory Journal, 17 (1), 59-69. doi: 10.1111/crj.13563 |
|
2023 Journal Article GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infectionFoo, Cheng Xiang, Bartlett, Stacey, Chew, Keng Yih, Ngo, Minh Dao, Bielefeldt-Ohmann, Helle, Jayakody Arachchige, Buddhika, Matthews, Benjamin, Reed, Sarah, Wang, Ran, Smith, Christian, Sweet, Matthew J., Burr, Lucy, Bisht, Kavita, Shatunova, Svetlana, Sinclair, Jane E., Parry, Rhys, Yang, Yuanhao, Lévesque, Jean-Pierre, Khromykh, Alexander, Rosenkilde, Mette Marie, Short, Kirsty R. and Ronacher, Katharina (2023). GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection. European Respiratory Journal, 61 (3) 2201306, 1-15. doi: 10.1183/13993003.01306-2022 |
|
2022 Journal Article Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator eraDavidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342 |
|
2022 Journal Article Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence TaskforceWhite, Heath, McDonald, Steve J, Barber, Bridget, Davis, Joshua, Burr, Lucy, Nair, Priya, Mukherjee, Sutapa, Tendal, Britta, Elliott, Julian, McGloughlin, Steven and Turner, Tari (2022). Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce. Medical Journal of Australia, 217 (7), 368-378. doi: 10.5694/mja2.51718 |
|
2022 Journal Article Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contactsWang, Yiming, Taylor, Steven L., Choo, Jocelyn M., Papanicolas, Lito E., Keating, Rebecca, Hindmarsh, Kate, Thomson, Rachel M., Morgan, Lucy, Rogers, Geraint B. and Burr, Lucy D. (2022). Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contacts. Chest, 162 (1), 56-65. doi: 10.1016/j.chest.2022.01.045 |
|
2022 Journal Article Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung diseaseRigauts, Charlotte, Aizawa, Juliana, Taylor, Steven L., Rogers, Geraint B., Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie L., Burr, Lucy, Willems, Anne, Tunney, Michael M., Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbé, Aurélie (2022). Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. European Respiratory Journal, 59 (5) 2101293, 1-16. doi: 10.1183/13993003.01293-2021 |
|
2022 Journal Article Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistanceBurr, Lucy D., Taylor, Steven L., Richard, Alyson, Schreiber, Veronika, Lingman, Stevie, Martin, Megan, Papanicolas, Lito E., Choo, Jocelyn M. and Rogers, Geraint B. (2022). Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistance. Antimicrobial Agents and Chemotherapy, 66 (4) e02246-21. doi: 10.1128/aac.02246-21 |
|
2022 Journal Article Targeting the P2Y13 receptor suppresses IL-33 and HMGB1 release and ameliorates experimental asthmaWerder, Rhiannon B., Ullah, Md Ashik, Rahman, Muhammed Mahfuzur, Simpson, Jennifer, Lynch, Jason P., Collinson, Natasha, Rittchen, Sonja, Rashid, Ridwan B., Sikder, Md Al Amin, Handoko, Herlina Y., Curren, Bodie F., Sebina, Ismail, Hartel, Gunter, Bissell, Alec, Ngo, Sylvia, Yarlagadda, Tejasri, Hasnain, Sumaira Z., Lu, Wenying, Sohal, Sukhwinder S., Martin, Megan, Bowler, Simon, Burr, Lucy D., Martinez, Laurent O., Robaye, Bernard, Spann, Kirsten, Ferreira, Manuel A. R. and Phipps, Simon (2022). Targeting the P2Y13 receptor suppresses IL-33 and HMGB1 release and ameliorates experimental asthma. American Journal of Respiratory and Critical Care Medicine, 205 (3), 300-312. doi: 10.1164/rccm.202009-3686oc |
|
2021 Conference Publication The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway diseaseRigauts, Charlotte, Aizawa, Juliana, Taylor, Steven, Rogers, Geraint, Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie, Burr, Lucy, Willems, Anne, Tunney, Michael, Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbe, Aurelie (2021). The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.PA873 |
